Literature DB >> 13812581

Metabolic studies of 32P-labelled triethylenethiophosphoramide.

A W CRAIG, B W FOX, H JACKSON.   

Abstract

Entities:  

Keywords:  ANTINEOPLASTIC AGENTS/metabolism

Mesh：

Substances：

Year:  1959        PMID： 13812581     DOI： 10.1016/0006-2952(59)90007-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  9 in total

Review 1.  THE TOXICOLOGY OF CHEMOSTERILANTS.

Authors:  W J HAYES
Journal:  Bull World Health Organ       Date:  1964       Impact factor: 9.408

2.  Long-term pharmacokinetics of thio-TEPA, TEPA and total alkylating activity following i.v. bolus administration of thio-TEPA in ovarian cancer patients.

Authors:  B Hagen; G Neverdal; R A Walstad; O G Nilsen
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  Pharmacokinetics of thio-TEPA and TEPA in the conventional dose-range and its correlation to myelosuppressive effects.

Authors:  B Hagen
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

4.  Metabolic studies with certain ethyleneimine derivatives in relation to diuresis.

Authors:  H Jackson; R M James
Journal:  Br J Pharmacol Chemother       Date:  1965-08

5.  Influence of the tissue distribution of ThioTEPA and its metabolite, TEPA, on the response of murine colon tumours.

Authors:  M C Bibby; B J McDermott; J A Double; R M Phillips; P M Loadman; L Burgess
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

6.  The metabolism of hexamethylphosphoramide and hexamethylthiophosphoramide.

Authors:  A R Jones; J S Bertram
Journal:  Experientia       Date:  1968-04-15

7.  Metabolism and alkylating activity of thio-TEPA in rat liver slice incubation.

Authors:  B Hagen; O Dale; G Neverdal; S Azri; O G Nilsen
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

8.  Single and repeated dose pharmacokinetics of thio-TEPA in patients treated for ovarian carcinoma.

Authors:  B Hagen; F Walseth; R A Walstad; T Iversen; O G Nilsen
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

9.  On the search for new anticancer drugs 14: the plasma pharmacokinetics and tissue distribution of spin-labeled thio-TEPA (SL-O-TT).

Authors:  P L Gutierrez; B E Cohen; G Sosnovsky; T A Davis; M J Egorin
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.